ArticleBMC pharmacology & toxicology2026
Penetration and disruption of Salmonella typhimurium biofilm using synthesized citric acid doped zein nanocomposites.
Article in BMC pharmacology & toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the current global scenario, antimicrobial resistance poses a major challenge and significantly contributes to increasing human mortality. Among resistant pathogens, the Salmonella genus, particularly Salmonella enterica serovar Typhimurium (S. Typhimurium), plays a prominent role, with resistance further intensified under mature biofilm conditions. To address this challenge and mitigate the pathogenicity of this Gram-negative bacterium, various strategies have been explored, among which nanodrug delivery using nanocomposites (NCs) has emerged as a promising approach. In the present study, NCs were developed by incorporating citric acid (CA) into zein nanoparticles (NPs) at defined concentrations. X-ray diffraction analysis confirmed the successful formation of CA@Zein NCs, while field-emission scanning electron microscopy (FE-SEM) verified the effective loading of CA onto the surface of zein NPs. Particle size, zeta potential, and polydispersity index analyses indicated optimal physicochemical properties for stable nanocomposite formation. The synthesised NCs were evaluated against both planktonic and biofilm forms of S. Typhimurium. The minimum inhibitory concentration and minimum biofilm inhibitory concentration of CA@Zein NCs were determined to be 64 µg/mL and 128 µg/mL, respectively. These results demonstrate the superior antibiofilm efficacy of CA@Zein NCs compared with CA and zein NPs alone. Furthermore, FE-SEM analysis provided direct evidence of EPS penetration and bacterial cell disruption by CA@Zein NCs. Overall, CA@Zein NCs exhibits strong potential as an effective antibiofilm agent against S. Typhimurium.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.